Transport of nanomedicines across the blood-brain barrier: Challenges and opportunities for imaging and therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transport of nanomedicines across the blood-brain barrier: Challenges and opportunities for imaging and therapy

Published:2022-10 Issue: Volume:141 Page:213125
ISSN:2772-9508
Container-title:Biomaterials Advances
language:en
Short-container-title:Biomaterials Advances

Author:

van den Broek Sara Lopes,Shalgunov Vladimir,Herth Matthias M.

Funder

Horizon 2020

H2020 Marie Skłodowska-Curie Actions

Publisher

Elsevier BV

Subject

Biomaterials,Biomedical Engineering,Bioengineering

Reference176 articles.

1. Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases;Anthony;Life Sci.,2021

2. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016;Feigin;Lancet Neurol.,2019

3. Current strategies for brain drug delivery;Dong;Theranostics,2018

4. Can the pharmaceutical industry reduce attrition rates?;Kola;Nat. Rev. Drug Discov.,2004

5. The role of multidrug resistance protein (MRP-1) as an active efflux transporter on blood–brain barrier (BBB) permeability;Lingineni;Mol. Divers.,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Latest Perspectives on Alzheimer’s Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems;Molecules;2024-08-27

2. A Scoping Review of Focused Ultrasound Enhanced Drug Delivery for Across the Blood–Brain Barrier for Brain Tumors;Operative Neurosurgery;2024-05-08

3. Advances in carrier-delivered small interfering RNA based therapeutics for treatment of neurodegenerative diseases;Biomaterials Science;2024

4. Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management;Pharmaceutics;2023-12-29

5. Improving the efficacy of anti-EGFR drugs in GBM: Where we are going?;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3